Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer. - Wikidata - awgldk - TriplyDB

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

http://www.wikidata.org/entity/Q33688715

about

Positron emission tomography to assess hypoxia and perfusion in lung cancer Hypoxia and tissue destruction in pulmonary TB Functional imaging in adult and paediatric brain tumours.Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence 18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.Modelling and detecting tumour oxygenation levels.Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.Image-derived input function for brain PET studies: many challenges and few opportunities.Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer.Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma Kinetic modeling in PET imaging of hypoxia.Nitroimidazole derivatives: a patent review of US 2014/0141084 A1.Functional imaging for radiotherapy treatment planning: current status and future directions-a review.Hypoxia imaging and radiotherapy: bridging the resolution gap.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).Quantitative Analysis of [18F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry.Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models.18 F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling Parametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.Impact of tissue transport on PET hypoxia quantification in pancreatic tumours.Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.Towards clinically translatable in vivo nanodiagnostics.

P2860

Q27026940-66D5D95F-D5A2-4498-AE39-453FE4736E7C Q28817961-125DF5D2-9C24-4FA1-A2DC-AFC91F959AEA Q30577397-F0012A9F-B820-4252-B9F5-1A4BF26BE90E Q31165401-607E17D1-8BD5-4700-BFD0-E770F0C7E2F3 Q33818999-DBFAEC61-D55A-4F3B-84DB-6B6AB3AD5924 Q33820595-887AE22E-878A-4592-9D71-3A97823E5031 Q34325735-94847F7F-6B0D-4187-B051-63BB2A91C610 Q35402102-8F007945-3DF2-411C-B8B3-039D441A9176 Q35524029-F8E6C842-31EB-4107-B3DF-0D317704A0D2 Q36335266-5124054D-44C2-4B8B-86E9-96CE1A219DAB Q36529838-F6A9F838-5BCB-4CA3-B7DE-02F81C18B5D8 Q36940477-7EAADC4F-F245-439D-9431-CC4159D1F34D Q37119863-6AF69C50-A4F6-4792-BCC8-CDFC38ADB38C Q37161068-3D76859F-5A63-4584-9CA0-3FFA80D86AD4 Q37496776-3313C87F-94A6-4B28-8FFE-82D427DB5A56 Q38101933-42100391-C78A-4CD9-99DC-2FF943940250 Q38253648-A0421179-F371-40E6-B5BD-D5B7DA8F4138 Q38340260-CB8137F3-8F7A-4BBB-B0C8-E3642CEBEA44 Q38397651-7895B8E2-23FD-452F-B427-053A4BE9FDC1 Q38400842-0D8C177B-15F0-4F35-B4CD-F39222F440BC Q38936273-86D818F9-800E-4093-B97A-AA0B41954AD3 Q39630464-B807C890-4FF9-44DC-ABE6-8D507E40AC65 Q41467964-6E7789FB-7DC4-49E0-87B2-62A0FDCA28B5 Q41733566-4DFEB5B8-6ACD-4917-B36A-A404F07B2359 Q41947399-9D1591CA-6EC7-4E60-BE84-9E72561FAE23 Q42098251-231C8283-AEB0-499E-AEED-2BC42ACD1E8B Q42124600-BB9280F6-3EA9-46AF-98EB-08CF156A7ED0 Q47115519-FAB6FA5A-C3DB-4598-96C3-DAF220F4D6B6 Q53064658-D710B724-B8A9-4893-83B2-C99A0CF2D567 Q53193315-76582A61-A16F-48F9-B5B1-6B504A39F55E Q53273186-F05F3CE4-AC57-48FA-A0FB-03826DF856AF Q54985361-A0A69BCD-E2F6-480B-A45A-82F2FF2909E6

P2860

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

http://www.wikidata.org/entity/Q33688715

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@ast

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@en

type

label

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@ast

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@en

prefLabel

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@ast

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@en

P1433

Q33688715-AB59AD3B-5BD7-4623-85A4-068C5326E6DD

P1476

Q33688715-990B65C0-5DD1-4CBF-8DDF-23A7B13C3BAA

P2093

Q33688715-00BFB95C-58C8-42DB-A7E1-04FFA1F087D6

Q33688715-0D6D45A8-BB11-4EDB-B204-834A6B217505

Q33688715-42396AFC-00D9-4B39-827B-03331FDD8942

Q33688715-6572B52B-A8B2-4416-B2ED-9179438DD622

Q33688715-74D8F7A0-F543-4B9F-A3FC-F2BF075E9337

Q33688715-8660BF7C-6806-4F28-AC30-3FA0899F4699

Q33688715-B5B0F674-2D40-42DC-8181-1F5F22753C24

P2860

Q33688715-15FDDE5C-2A3D-4190-BD30-DEB2EB4CDFAC

Q33688715-426C1B62-3703-4ACD-BA30-66BE76BF1648

Q33688715-5683E1C8-0DD4-4A60-AE6C-31087B7CF51C

Q33688715-58A290C2-64F9-406A-8C44-574A3611BA31

Q33688715-6CE46F73-0D8F-4F6A-AB41-3DD55B8D43C0

Q33688715-6DF3ABA1-D401-4175-A101-ADC19E127D64

Q33688715-714BA858-BEAA-4D49-B805-79E9DF4D6CB3

Q33688715-795C23C2-C824-4EA6-8DA5-633E9D783769

Q33688715-8010A115-93D5-4CA9-A7A7-648DED301CDC

Q33688715-CEE4A566-DC2E-4006-A170-AC687F8A1B88

P304

Q33688715-D6D80FA8-0EA1-49F4-A104-F7612F8D431F

P31

Q33688715-D7E5E328-79B9-4295-94C5-2EBB1EBE21C4

P356

Q33688715-2E8A1F31-BEE2-4151-B2E1-DC67672A97D5

P407

Q33688715-14B64EBA-7E03-473F-89B5-6601FCB3380C

P433

Q33688715-E64A4801-6E6C-4A79-BF00-7E78FEFF3BC8

P478

Q33688715-F381E205-2DAE-45BE-942E-B9A28ED7E516

P577

Q33688715-588BFE14-EC1B-451D-A2C7-12FB1403C1EC

P5875

Q33688715-BCD69F4B-2FE6-42A7-A09D-C01796DDBEA9

P698

Q33688715-7F585FEC-B796-4C45-9196-A66BDA91CD3B

P921

Q33688715-0AFD8242-50A1-473C-88BB-4FE9726067B5

P932

Q33688715-9956A41B-DEE1-45FF-A076-392380A54750

P356

JNUMED.109.067009

P1433

The Journal of Nuclear Medicine

P1476

Pharmacokinetic analysis of hy ...... c PET in head and neck cancer.

@en

P2093

Heiko Schöder

http://www.w3.org/2001/XMLSchema#string

Jens-Christoph Georgi

http://www.w3.org/2001/XMLSchema#string

John L Humm

http://www.w3.org/2001/XMLSchema#string

Jose Guillem

http://www.w3.org/2001/XMLSchema#string

Manoj Narayanan

http://www.w3.org/2001/XMLSchema#string

Nancy Y Lee

http://www.w3.org/2001/XMLSchema#string

Wenli Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the pu

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells.

Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

P304

37-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.109.067009

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40686699

http://www.w3.org/2001/XMLSchema#string

P698

20008982

http://www.w3.org/2001/XMLSchema#string

P921

P932

2828684

http://www.w3.org/2001/XMLSchema#string